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Abstract
The Coronavirus Disease (COVID-19) caused by severe acute respiratory syndrome coro-
navirus 2 (SARS-CoV-2) first appeared in Wuhan, China in late 2019 and since then has
caused unprecedented economic and social disruption as well as presenting a major chal-
lenge to public health. Despite mass progress in COVID-19 vaccination uptake, vaccine
hesitancy or anti-vax information has been reported that can delay public acceptance of a
vaccine. An online cross-sectional survey (n = 439) assessed COVID-19 vaccine uptake
and hesitancy in adults in Northern Ireland and the Republic of Ireland. Participants com-
pleted an adapted version of the Theory of Planned Behaviour Vaccine Questionnaire, the
Vaccine Attitudes Scale (VAX), Vaccine Confidence Scale, and questions on previous expe-
rience of COVID-19. Results showed that 66.7% of the sample intended to get a vaccination
as soon as possible, 27.15% reported they will get a vaccine when others get theirs and
when it is clear there are no side effects. 6.15% had no intention of getting a vaccine. Over-
all, there is a high mean intention (M = 6.12) and confidence to get a COVID-19 vaccine.
There was low vaccine hesitancy (M = 2.49) as measured by the VAX scale. A further analy-
sis of the sub factors of the VAX showed there is uncertainty and mistrust of side effects for
children. The finding demonstrate that the Theory of Planned Behaviour can be useful in
making recommendations for public health considerations when encouraging vaccine
uptake and reducing vaccine hesitancy.
Introduction
The Coronavirus Disease (COVID-19) caused by severe acute respiratory syndrome coronavi-
rus 2 (SARS-CoV-2) first appeared in Wuhan, China in late 2019 (World Health Organisation,
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2020) and since then has caused unprecedented economic and social disruption as well as pre-
senting a major challenge to public health (World Health Organisation, 2020). As of March
12th, 2021, the disease has infected more than 118,707,983 people with 2, 631,385 deaths world-
wide. In Europe there has been 38,947,362 confirmed cases and 881,973 reported deaths [1]. In
the United Kingdom, 4.26 million (England = 3.73m; Scotland = 210K; Wales = 207K; North-
ern Ireland = 115K) cases of coronavirus and 126,000 (England = 111K; Scotland = 7,510;
Wales = 5,454; Northern Ireland = 2099) deaths are reported [1], while in the Republic of Ire-
land 227K confirmed cases and 4,534 deaths were reported.
To restrict the spread of the virus, and reduce demand on health services, governments
worldwide introduced lockdown and quarantine measures, social distancing, and restrictions
in face to face education, workplace and commercially available shopping services. The impact
of these restrictions has been an increase in unemployment rates, employees being furloughed,
business disruption and school and university closure, with children being home schooled by
parents/family, and university teaching being delivered online.
SARS-Cov2 vaccine
The development of an effective SARS-Cov2 vaccine to avoid further human and social, and
economic loss was required. Vaccinations are an important method of public health disease
prevention involving the administration of a microorganism in a live, killed or weakened state
to stimulate immunity against disease (Centers for Disease Control and Prevention, 2018).
The development of a vaccine was expedited by the United Kingdom (UK) Government Vac-
cine Taskforce (VTF) with several SARS-Cov2 vaccine trials undertaken to identify which vac-
cines are both safe and effective, so that vaccination programmes can start as early as possible.
On the 8th December 2020 the first person in the UK received a Coronavirus vaccination,
since then efforts to roll out the vaccine have been encouraging and at pace. As of March 15th,
2021, 24, 453,221 individuals in the UK have received their first vaccine dose, while 1,610,280
have received a second dose. In Northern Ireland 629,461 had received a first dose and 54,636
had received a second dose of a vaccine by 15th March 2021 [2] Vaccine distribution is differ-
ent between NI and Republic of Ireland. The first dose of the Coronavirus vaccination in the
Republic of Ireland was administered on the 29th December 2020 and, as of the 13th March
2021, 451,589 individuals received a first vaccine dose while 164,345 had received a second
dose in the Republic of Ireland [3].
Encouragingly, 79% of 140,000 people surveyed in 140 countries indicated vaccines are safe
and 73% reported that they trusted a doctor or nurse more than any other source of health
advice [4]. From the same survey of UK respondents (n = 1000) 75% felt that vaccines were
safe, and 95% of those with children have had their children vaccinated. These figures are simi-
lar to those in the Republic of Ireland, where 73% of participants felt vaccines were safe, and
93% have had their children vaccinated. However, safety updates have been issued for both the
AstraZeneca [5] and Janssen [6] vaccines that may impact public confidence in COVID-19
vaccine uptake.
Vaccine hesitancy
Despite the progress in the public health distribution of the vaccinations, there are individuals
who will perceive vaccination as unsafe and/or unnecessary [7]. Vaccine hesitancy is defined
as the delay in acceptance or refusal of a vaccine despite their availability to the public [8]. Pre-
dicting vaccine hesitancy is complex because it is context and time specific, and can vary across
vaccines. Pre COVID-19, vaccine hesitancy was listed as one of the top ten threats to global
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public health, as a result it was recommended that countries incorporate plans to measure and
address vaccine hesitancy into their public health programmes [9].
There are several explanations for vaccine hesitancy, some of which are medical and ethical
concerns that have been in existence since the emergence of vaccines in the 1700’s [10,11]
Recently, in 2018 [12] the WHO identified confidence (i.e. trust in the vaccine safety and ser-
vice providers), complacency (i.e. lack of perceived benefits of the vaccine and low sense of
risk), and inconvenience in accessing vaccines as some of the key reasons underlying vaccine
hesitancy. Several psychological factors are demonstrated to influence COVID-19 vaccine hes-
itancy. These include: low altruistic beliefs about the need to protect others; personality traits
such as neuroticism and conscientiousness, conspiracy, religious beliefs, paranoid beliefs, mis-
trust of authority and the attitudes and behaviour of others (family, friends and health profes-
sionals) towards vaccines [13,14].
Factors found to increase hesitancy include: forgetting to register for a vaccine, location of
the vaccine centre, misinformation, lack of disabled access, previously declining a vaccine, a
preference for natural immunity and worries about unforeseen future side effects of receiving
a vaccine.
Vaccine hesitancy and children
Vaccine hesitancy does not appear to be the same across the population. Over a decade ago
hesitancy was reported to be on the rise amongst parents (Gowda & Dempsey, 2013) with con-
cerns and a distrust about the potential side effects vaccines can have on children in the imme-
diate and short-term. This distrust in vaccines for children may be in part due to a discredited
case series in the Lancet [15] that suggested measles, mumps and rubella (MMR) vaccine pre-
disposed children to behavioural regression and pervasive developmental disorder [16]. The
Lancet publication led to a plethora of studies, refuting the link between autism and vaccina-
tion [17,18], although damage to parental confidence, and public opinion on vaccine certainty
for children may have already occurred, evident in a measles outbreaks in the UK, USA and
Canada in 2008/2009 due in part to parental hesitancy and children not being vaccinated [19].
This finding suggests that public health authorities and effective communication to the public
plays an important role in ensuring scientific guidance and information on vaccines is not mis-
leading, and that anti-immunisation rhetoric or fashionable conspiracy theories are down-
played. According to [20] online anti-immunisation videos have gained a large viewing by the
public, and social media support. The effects of anti-vaccine media have been shown to influ-
ence public attitudes, beliefs, and perceived social norms as predictors of vaccine uptake [21].
A study of teenagers has shown that little is known about how vaccines work, and how booster
vaccines for the likes of Meningitis C can protect from the disease. In the same study the par-
ticipants experiences of immunisation in school were not always positive, however they were
enthusiastic at the prospect of introducing more vaccines for their age group [22]. Further-
more, in a qualitative study of teenage girls, parents and health professionals views of the Mea-
sles, Mumps, Rubella (MMR), the Human Papilloma virus (HPV) and the Influenza A (H1N1)
vaccine showed that having a little bit of doubt about a vaccine, can lead to uncertainties to
vaccinations in general, this finding may have implications for hesitancy to receiving the
COVID-19 vaccine [23].
Vaccine hesitancy and COVID-19
Unfortunately, COVID-19 vaccine hesitancy research is limited in both Northern Ireland and
the Republic of Ireland making public health decisions regarding communicating effectively
with the public more difficult. A study by Murphy et al [13] examined the factors that influence
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vaccine hesitancy and uptake. They showed 35% of those in Republic of Ireland and 48.9% in
Northern Ireland were hesitant. These figures are particularly concerning given recent
research into the contagiousness and rapid spread of the virus, the findings of which suggest
that between 55 and 82% of a population should be immune (either via exposure or vaccina-
tion) to the virus in order to prevent its spread [24].
The survey by Murphy and colleagues [13] was conducted during the first COVID-19
national lockdown when a vaccine had not been developed, hence views of the public on a
future potential vaccine could be very different from views on a vaccine that is available. Fur-
thermore, a small sample size from Northern Ireland (n = 46) took part. To date, no studies
have included a psychological behaviour change theory to predict COVID-19 vaccine uptake
that would provide a further level of detail when advising national public health authorities.
Psychologically oriented informative campaigns have proven effective in promoting health
behaviours [25], and a recent rapid review also supports this view [26], therefore the findings
of the current study may be beneficial to future campaigns which aim to increase vaccine
uptake.
Psychological theories of behaviour change
Several psychological behaviour change theories have their origins in social, and cognitive sci-
ences, and explain, how and why individuals engage in intentional health behaviours [27,28].
By integrating psychological behaviour change theory such as the Theory of Planned Behav-
iour (TPB) into survey design of health intention and behaviours, the psychological mecha-
nisms of behaviour change can be better understood, then operationalized when making
recommendations on public health messaging (National Institute for Health & Care Excel-
lence, 2018).
The TPB [29] states that an individual’s attitudes/beliefs, subjective norms and perceived
behavioural control predict intentions and subsequent behaviours. The TPB has been used
previously to explain vaccine uptake, although the current study is the first where TPB will be
applied to COVID-19 vaccine uptake and hesitancy. As already described, there are many fac-
tors that can predict hesitancy and uptake, so in addition to TPB factors, other factors will be
included as predictors. These other factors include: Participant Demographics (Age, Gender,
Employment, Educational Level, Ethnicity), and Previous Experience of COVID-19 (i.e., having
had a positive test for COVID-19, having had to self-isolate, knowing someone who has had
COVID-19, knowing someone who has had a vaccine or being at an increased risk of COVID-
19). Finally, as mistrust and confidence in the effectiveness of vaccines has been a reported
issue for parents consenting to children receiving vaccines, parental mistrust and confidence
in children being vaccinated was also included.
Aims of the study
As there are gaps in the literature in the rates of vaccine uptake and hesitancy, and how to pro-
mote vaccine uptake using a psychological theory of behaviour change the study had three
aims: 1) To assess SARS-CoV-2 vaccine uptake and hesitancy rates in Northern Ireland and
the Republic of Ireland where the healthcare systems are different, yet there is overlap in
culture; 2) To assess Attitudes, Subjective Norms and Perceived Behavioural Control as predic-
tors of intentions to vaccinate against COVID-19 and 3) To consider demographic factors,
confidence in getting a vaccine and previous experiences of COVID-19 on intention to
vaccinate.
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Materials and methods
Participants
A total of 439 participants took part with 386 (Mean Age = 42.23; SD = 12.16; Range = 19–81;
83% = female, 17% = male) completing all questions.
Research design
A cross-sectional survey was conducted online via Qualtrics. Participants were recruited via
social media platforms Twitter, Facebook and by the Public Health Agency for Northern Ire-
land’s COVID-19 Behaviour Change Cell. No financial incentives were provided to social
media organisations or participants for taking part.
Recruitment
Participants were recruited via social media platforms, Twitter and Facebook. Data was col-
lected via a Qualtrics survey between 29/01/2021–23/02/2021 (i.e. seven weeks after the first
COVID-19 Vaccination, and during a national lockdown in NI and ROI).
Measures
Previous experience of COVID-19. All participants were asked whether they: had had a
positive test for COVID-19; are at an increased risk of COVID-19; have had to self-isolate;
knew someone with COVID-19; knew someone who had received a COVID-19 vaccination.
Vaccine Confidence Scale [30]. Consists of eight items assessing three factors: benefits of
vaccination (Benefits), the harms of vaccination (Harms), and trust in health care providers
(Trust). Each item used an 11-point response scale ranging from 0 (strongly disagree) to 10
(strongly agree). The scale is valid and reliable across many diverse populations [30].
Vaccine Attitudes Examination Scale (VAX) [31]. Consists of 12 items assessing four
factors (vaccine mistrust, future worries, profiteering, and preference for natural immunity).
Items were presented in the form of statements, with responses on a 6-point Likert-type scale
ranging from “strongly agree” to “strongly disagree.” Higher scores reflect stronger anti-vacci-
nation attitudes.
Adapted version of theory of planned behaviour vaccine questionnaire [32]. Consists
of 19 items that assess Attitudes (5 items), Subjective Norm (6 items), Perceived Behavioural
Control (5 items) and Intentions (3 items) to receive a COVID-19 vaccination. The score on
intentions was the main outcome variable to assess behavioural intentions to get the COVID-
19 vaccine. Items were presented in a 7-point Likert Scale ranging from “strongly disagree” to
“strongly agree”. In the absence of a COVID-19 questionnaire, the original scale was adapted
to include the word COVID-19 in items when referring to vaccination to make the scale spe-
cific to assessment of COVID-19.
An example question assessing Attitudes was ‘Using the scales provided, please select the
response which reflects your feelings towards the following statements—Getting a COVID-19
vaccine would have definite benefits for my health. For Subjective Norms: ‘Using the scales
provided, please select the response which reflects your feelings towards the following state-
ment—Most people who are important to me think that I should get a COVID-19 vaccine’.
For Perceived Behavioural Control: ‘Using the scales provided, please select the response
which reflects your feelings towards the following statement—I am confident that if I want to,
I will be able to get a COVID-19 vaccine’. Cronbach’s alpha reliability coefficient was calcu-
lated for TPB variables, Attitudes = .9, Subjective Norm, = .89 Perceived Behavioural Control
= .06 and Intention = .94. As Cronbach’s alpha level was low for PBC indicating that the items
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were weakly related, the scale was recalculated using two items, which showed a moderate cor-
relation (r = 0.4).
Ethical approval
Ethical approval was granted by Ulster Universities School of Psychology Research Ethics Fil-
ter Committee. All participants were provided with a description of the aims and rationale for
the study and were asked to provide written informed consent before completing the survey.
Participants were free to withdraw at any time. No personal identifying data was collected to
ensure confidentiality.
Data handling
The mean or sum of participants’ responses were calculated as per the scoring criteria for each
measure. Analysis was conducted using Statistical Package for the Social Sciences 26 (copyright
IBM corp., NY, USA) with the alpha level set to p< .05. Pearson’s correlations were consid-
ered weak, moderate and strong when r = .1, .3 and .5 respectively. Effect sizes for t-tests were
interpreted using Cohen’s d where small, medium and large effects were classed as .20, .50 and
.80 respectively. Given the sample size was n = 386, central limit theorem inferred the data was
normally distributed. Levene’s tests confirmed homogeneity of variances for all statistical tests
henceforth. Pearson’s bivariate correlations were conducted to assess whether relationships
existed between TPB factors, VAX, VCS. Independent samples t-tests assessed whether there
was a significant difference in gender or country (NI and ROI). Linear Regression analysis was
calculated to establish a best fit model for predicting vaccine intentions.
Results
Participant demographics
Demographic information is described in Table 1.
Experience of COVID-19
When participants were asked about COVID-19, 10.6% reported having had a positive test for
COVID-19, 43.3% reported that they had to self-isolate. Almost 20% of the sample considered
themselves to be in an increased risk category for Covid-19, 56% said a family member or
friend had had COVID-19, and 87.6% reported that they knew someone who had received the
COVID-19 vaccine.
Intentions, attitudes and confidence levels towards receiving a COVID-19
vaccine
Almost 67% intended to get a vaccine as soon as possible, 27.2% reported that they will get
their vaccine when others receive theirs and when it is clear there are no side effects, and 6.2%
had no intention of getting a vaccine. Descriptive data for the VCS, VAX and TPB factors is
presented in Table 2.
There was a high level of confidence (7.98) in getting the COVID-19 vaccine as indicated in
the CVS scale. There was also a high mean intention score (6.12) to get a COVID-19 vaccine.
A low mean score (2.49) on the VAX scale indicated low vaccine hesitancy in the sample. The
mean scores for the sub-factors of the VAX scale were calculated. Presented in order from
highest to lowest, these included: worry about unforeseen future events as a result of the vac-
cine (mean = 3.32, SD = .82), preference for natural immunity (mean = 2.44, SD = .9),
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pharmaceutical company profiteering (mean = 2.17, SD = .98) and mistrust of vaccine benefit
(mean = 1.97, SD = .89).
The mean scores for the TPB sub factors (Perceived Behavioural Control, Subjective Norms
and Attitudes) indicated that attitudes, PBC and subjective norms contributed to deciding to
get a vaccine. No gender effects were found for any of the scales (p>.05), however there was
a significant positive correlation between age and intention to get the vaccine (r = .2, df = 331,
p< .01).
Relationship between CVS, VAX and TPB scales on intention to get
vaccinated
Pearson Product Moment bivariate correlations were calculated for each scale (VCS, VAX,
TPB (perceived behavioural control, subjective norm, attitudes towards COVID-19 vaccine)
with intention to vaccinate against COVID-19 (see Table 3).
Confidence in the COVID-19 vaccine was positively correlated with intention to receive
the vaccine. Attitudes, perceived behavioural control and subjective norms were positively
Table 2. Mean score, standard deviation, range and possible range for the Vaccine Confidence Scale, Vaccine Atti-
tudes Examination (VAX) scale and theory of planned behaviour subscales (Attitudes, subjective norms, perceived
behavioural control and intention to get a vaccine) are presented.
M SD Range Possible Range
Vaccine Confidence Scale 7.98 1.79 1–10 1–10
Vaccine Attitudes Examination (VAX) Scale 2.49 .77 1–5 1–5
TPB Attitudes scale 5.66 1.38 1–7 1–7
TPB Subjective Norm scale 5.64 1.34 1–7 1–7
TPB Perceived behavioural control 5.66 1.38 1–6 1–7
TPB Intention to get a vaccine 6.12 1.5 1–7 1–7
https://doi.org/10.1371/journal.pone.0259381.t002
Table 1. Sample demographics.
Participants (n = 386) %
Gender: Male 17
Female 83
Country: Northern Ireland 53
Republic of Ireland 43





Educational Achievement: Bachelor’s Degree 7.3
Master’s Degree 13.2
PhD or Higher 11.7
Trade/School 39.1
Prefer not to say 28.8
Employment Status: Employed full-time 53.4
Employed part-time 19.2
Retired 9.6
Unemployed seeking employment 5.3
Furloughed as a result of COVID-19 6.7
Prefer not to say 6
https://doi.org/10.1371/journal.pone.0259381.t001
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correlated with intention to get the vaccine. Anti-vaccination attitudes as measured by the
VAX were negatively correlated with intention to get a vaccine.
To identify what VAX items are correlated with intention to vaccinate, the four subfactors
of the VAX scale i) mistrust of vaccine benefit, ii) worries about unforeseen future events, iii)
concerns about future profiteering, and iv) preference for natural immunity were correlated
with intention to get a vaccine (See Table 4). All four factors negatively correlated with inten-
tion to vaccinate, with mistrust of vaccine benefit showing the largest correlated coefficient.
To determine what factors predicted intention to vaccinate, a Linear Regression model was
calculated using questions on gender and experiences of COVID-19, CFS, VAX and TPB vari-
ables (See Table 5). The regression model explained 71% of the variance in intentions (F
Table 3. Pearson product moment bivariate correlations between VCS, VAX and TPB scales.










1 -.809�� .5�� .629�� .757�� .7��
Sig. (2-tailed) < .001 < .001 < .001 < .001 < .001
N 361 349 333 333 333 333
VAX Pearson
Correlation
-.809�� 1 -.568�� -.622�� -.769�� -.720��
Sig. (2-tailed) < .001 < .001 < .001 < .001 < .001





.219�� -.223�� 1 .285�� .301�� .277��
Sig. (2-tailed) < .001 < .001 < .001 < .001 < .001
N 333 334 334 334 334 334
TPB Subjective Norms Pearson
Correlation
.629�� -.622�� .539�� 1 .732�� .669��
Sig. (2-tailed) < .001 < .001 < .001 < .001 < .001
N 333 334 334 334 334 334
TPB Attitudes Pearson
Correlation
.757�� -.769�� .574�� .732�� 1 .827��
Sig. (2-tailed) < .001 < .001 < .001 < .001 < .001
N 333 334 334 334 334 334




.700�� -.720�� .561�� .669�� .827�� 1
Sig. (2-tailed) < .001 < .001 < .001 < .001 < .001
N 333 334 334 334 334 334
��. Correlation is significant at the .001 level (2-tailed).
https://doi.org/10.1371/journal.pone.0259381.t003









Intentions Mean for all
questions




-.706�� -.521�� -.631�� -.536�� 1
Sig. (2-tailed) < .001 < .001 < .001 < .001
N 334 334 334 334 334
��. Correlation is significant at the 0.01 level (2-tailed).
https://doi.org/10.1371/journal.pone.0259381.t004
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(14,317) = 58.79, p< .001). Attitudes, perceived behavioural control and the VAX mistrust
factors were the statistically significant variables explaining COVID-19 vaccine intention.
High VAX mistrust scores suggested a lower intention to get vaccinated against COVID-19,
whilst higher perceived behavioural control and attitude scores suggested a higher intention to
get vaccinated against COVID-19.
Discussion
The current study showed that attitudes towards COVID-19 vaccines, perceived behavioural con-
trol and mistrust predict the high mean intention to get the vaccine in this sample. These findings
support the application of the Theory of Planned Behaviour to explain intentions to vaccinate
against COVID-19. The data also showed that in the sample there was a high level of confidence
to get a COVID-19 vaccine (VCS) and a low vaccine hesitancy score (M = 2.49). This resonates
with the confidence factor identified by the WHO as a key predictor of vaccine hesitancy and cor-
roborates the findings of Murphy et al. [14] that psychological factors should be monitored when
predicting vaccine uptake, and extends the rationale for the inclusion of the Theory of Planned
Behaviour as a suitable basis on which to interpret vaccine uptake and hesitancy.
The finding that attitudes and perceived behavioural control is in keeping with previous
research findings which showed that having positive beliefs towards vaccines, feeling in control
of getting a vaccine and having people in your close circle of family or friends, especially those
who you respect, who received a vaccine influences vaccine acceptance [33]. The current study
extends previous studies on vaccine hesitancy to COVID-19, that was previously lacking. The
perception that friends and family are pro-vaccination can influence attitudes and vaccine
uptake, and the belief that others wanted them to receive a vaccination led them to be more
likely to vaccinate [34].
Mistrust in vaccines has also been noted in a recent study conducted in Italy, were willing-
ness to vaccinate against COVID-19 is correlated with trust in the research conducted and in
Table 5. Regression model.
Unstandardized
Coefficients
Standardized Coefficients t Sig.
B Std. Error Beta
Constant 5.680 .905 6.274 < .001
Gender .040 .121 .010 .334 .739
Have you had a positive test for COVID-19? .187 .162 .039 1.161 .247
Have you had to self-isolate at any point during the COVID-19 pandemic? .108 .101 .035 1.069 .286
Are you in an increased risk category for COVID-19? (e.g. ongoing illness) -.094 .113 -.025 -.830 .407
Has anyone close to you (i.e. family member or friend) had COVID-19? .017 .095 .006 .179 .858
Do you know anyone who has had a vaccine for COVID-19? .196 .149 .042 1.315 .189
PBC .104 .043 .095 2.405 .017
Sub Norms .092 .052 .082 1.766 .078
Attitudes .570 .064 .523 8.847 < .001
VAX mistrust factor -.194 .090 -.113 -2.155 .032
VAX worry factor .031 .076 .017 .401 .688
VAX profit factor -.110 .080 -.070 -1.370 .172
VAX immunity factor -.019 .075 -.011 -.250 .803
VCS .069 .047 .080 1.476 .141
a. Dependent Variable: Intentions.
https://doi.org/10.1371/journal.pone.0259381.t005
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vaccine effectiveness [35]. This study highlighted the decrease in Italian citizen’s trust in sci-
ence and vaccination at different stages of the pandemic and noted that the proportion of citi-
zens who appeared to be intentioned to get the COVID-19 vaccination would likely be too
small to effectively prevent the spread of the disease, if the 55 to 82% immunity statistic previ-
ously cited is to be applied [24].
Much of the attribution of responsibility for the decrease in trust of scientific research and
vaccination effectiveness is linked to both national and international media, whose coverage of
the debate surrounding vaccination will frequently lead to misunderstanding and mistrust of
vaccination if not adequately accompanied by appropriate health education [36]. This could be
related to the finding that a lack of confidence may predict vaccine hesitancy. Appropriate
health education in this context also extends to the description of the reasoning behind certain
preventative measures such as school and work closures.
Since the current survey was conducted, recent Astra Zenaca blood clotting reporting in
the UK media, and the temporary withdrawal of the vaccine in Republic of Ireland may under-
mine confidence in vaccine uptake and hence mistrust maybe higher than reported here,
highlighting the importance of maintaining positive public views towards vaccine uptake. This
public confidence in the Astra Zeneca vaccine may be further damaged by recent recommen-
dations from the Irish National Immunisation Advisory Committee (NIAC) that the vaccine
should only be given to those aged over sixty years old [37]. In the absence of psychological
informed recommendations, the current study fills this gap.
There are several recommendations from the current study, for example specific targeting
of the hesitant population to change attitudes may best be achieved through influencing atti-
tudes and mistrust, in practice this could be the generation of clear optics around health mes-
sages and campaigns that allow people who are hesitant to see and hear about others receiving
the vaccine. Research by Quinn and colleagues [38] has pointed towards significantly higher
rates of flu vaccination among American adults of differing race and religion, suggesting that
the influence of peer role models and attitudes may transcend ethnicity. Messaging could also
focus on reducing worry of the side effects of the vaccine, through the use of coherent and eas-
ily understandable information which is concise enough to retain the interest of the lay person
whilst effectively conveying the benefits and safety of vaccinations (e.g. posters, advertisements
etc.). We also highlight that the mutation of the SARS-CoV-2 is uncertain and vaccine effec-
tiveness may depend on continued vaccine developments, therefore continued creative
attempts to motivate the population to vaccination maybe required.
As previously cited, a significant majority of the population trust their healthcare providers
(HCPs) (The Wellcome Trust, 2019 [4]), meaning any future influencing of attitudes and per-
ceived competence should include some actions aimed towards health professionals and gen-
eral practitioners (GPs) who are viewed by their patients as models for their own health
behaviours [39]. A health promotion campaign spearheaded by such individuals who cham-
pion the benefits and positive outcomes of vaccinations should result in an increased uptake
and reduced vaccine hesitancy throughout the public, as the trust held by patients in their
HCPs begins to outweigh any mistrust or misinformation of vaccination.
An informative platform on the immunisation process may also be of great benefit to both
the public and HCPs, and suggestions have already been made for the development of a plat-
form similar to the Swiss INFOVAC academic network [40,41]. Such a platform would be a
huge outlet for questions on the immunisation process as well as general queries regarding
vaccinations, such as previous, non-COVID-19 rollouts and details of existing programmes.
Vaccine misinformation, which is any false information not backed by evidence, is believed
to be common on social media [42,43]. Some form of regulation of media debate regarding
vaccination should be considered, as the sensationalism of such a serious topic is the root of
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much of the existing vaccine mistrust [36]. This regulation should not restrict people from
expressing concerns over vaccine rollouts or preventative measures, as collaboration between
the public and science is crucial, especially in the current COVID-19 era [44]. Rather, engaging
messages and information should be made available to viewers and social media users who feel
the need to educate themselves on any COVID-19 vaccination related issues. Similar informa-
tion, about COVID-19 in general is already employed by popular social media outlets such as
Instagram, although a need for more direct, vaccination-oriented information is needed. A
small minority of the vaccine-critical misinformation online is thought to come directly from
bots [43] which may also be a useful tool for healthcare professionals to use in order to coun-
teract such misinformation.
The study had several limitations that should be considered when interpreting the findings.
The TPB provided a lens to explore the complex psychological and social factors underpinning
COVID-19 vaccine hesitancy, however a limit of the TPB is that there is no measure of emo-
tion (e.g., disgust) that have been shown to influence vaccine attitudes [45]. Furthermore, the
sample was mainly female (83%) and could have included more males. As the survey was com-
pleted 29th January- 23rd February, 7 weeks after the first vaccine was administered in North-
ern Ireland and 4 weeks after the first vaccine was administered in the Republic of Ireland, it is
possible views of the public can change in response to vaccines. Finally, the survey was cross
sectional, therefore it is not possible to make causal conclusions between the factors assessed
and intention to vaccinate. Therefore, further follow-up with longitudinal designs are required
and with measures that go beyond assessing intentions, but also incorporate behaviour.
To conclude, this study has some important strengths which may have bearing on future
research, such as the identification of the links between mistrust in vaccines, attitudes, per-
ceived behavioural control and intention to vaccinate. These relationships may provide an evi-
dence-based foundation for future research, with the incorporation of monitored
psychological factors seemingly becoming increasingly important in vaccine hesitancy
research [14]. Further long-term research is also required that evaluates adherence to multiple
doses of vaccinations and how younger age groups comply to public health guidance. Finally,
the suitability of the Theory of Planned Behaviour in predicting vaccine hesitancy in this study
suggests a need for the incorporation of behaviour change theories into public health messag-
ing of vaccines against COVID-19 and future pandemics.
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